Search Results for "pharmaceutical supply"

85 result(s) found

Scroll Down To Discover

Found 85 result(s)

© Image Copyrights Juris Services & Technology

Supreme Court Dismisses Appeal Against NPPA Demand for Overcharged Drug Prices. Appellant Held Liable as Distributor Under Paragraph 13 of DPCO 1995 Despite Claim of Being Only a Dealer.

The appellant, a pharmaceutical company, challenged demand notices issued by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Pri...

© Image Copyrights Juris Services & Technology

Bombay High Court Allows Drug Manufacturers in Challenge to Suspension of Licenses for Alleged Spurious Drugs. Suspension order set aside for violation of natural justice as no show-cause notice was issued before suspension under the Drugs and Cosmetics Act, 1940.

The petitioners, National Pharmaceuticals and AVEO Pharmaceuticals Pvt Ltd, are drug manufacturing companies holding licenses to manufacture drugs at ...

© Image Copyrights Juris Services & Technology

Supreme Court Quashes Blacklisting of Drug Manufacturer for Supplying Sub-Standard Cream Due to Reliance on Erroneous Test Report. Appellate Lab Report Under Section 25(4) of Drugs and Cosmetics Act, 1940 Held Conclusive, Ignoring It Renders Decision Perverse.

The appellant, Medipol Pharmaceutical India Pvt. Ltd., supplied Clotrimazole Cream 1% 15 gm tubes to the respondent, Post Graduate Institute of Medica...

© Image Copyrights Juris Services & Technology

Supreme Court Upholds Quashing of Notification Restricting Oxytocin Manufacture to Public Sector. Notification under Section 26A of Drugs and Cosmetics Act, 1940 held invalid for being arbitrary and disproportionate to the objective of curbing misuse.

The case involves a challenge to a notification issued by the Ministry of Health and Family Welfare under Section 26A of the Drugs and Cosmetics Act, ...

© Image Copyrights Juris Services & Technology

Bombay High Court Dismisses Bayer's Challenge to Compulsory License for Nexavar Under Section 84 of Patents Act, 1970. Court Holds That Patentee's Import of Drug at High Price Does Not Satisfy Reasonable Requirements of Public or Constitute Working of Invention in India.

The petitioner, Bayer Corporation, a US-based pharmaceutical company, held a patent for the drug Sorafenib Tosylate, sold under the brand name Nexavar...

© Image Copyrights Juris Services & Technology

Bombay High Court Hears Challenge to Drug Price Control Demand Against Pharmaceutical Company. Cream Vs. Ointment Distinction and Small Scale Industry Exemption Under DPCO 1995 Considered.

The writ petition arose from a dispute concerning the drug price control regime under the Drugs (Price Control) Order, 1995 (DPCO 1995). The first pet...

© Image Copyrights Juris Services & Technology

High Court of Karnataka Hears Challenge by Drug Supplier Against Blacklisting Order Alleging Non-Compliance with Rule 26A of Karnataka Transparency in Public Procurements Rules, 2000. Petitioner Assails Blacklisting as Ultra Vires in Absence of Corrupt Practice Finding and Procedural Violation.

The petitioner, a pharmaceutical company, filed a writ petition under Articles 226 and 227 of the Constitution of India before the High Court of Karna...